Form 4: RANGE IMPACT CEO Granted 250,000 Stock Options

RANGE IMPACT, INC. CEO Michael R. Cavanaugh received a grant of 250,000 stock options with an immediate vesting date.

Summary

• Michael R. Cavanaugh, CEO and Director of RANGE IMPACT, INC. (RNGE), was granted options to purchase 250,000 shares of common stock.
• The exercise price for these options is $0.15 per share.
• The options vested immediately upon grant on December 31, 2025.
• Following this transaction, Mr. Cavanaugh beneficially owns 3,350,000 derivative securities.
• The options have an expiration date of December 31, 2035.

Sentiment

Score: 7

Explanation: The grant of stock options to the CEO, especially with immediate vesting, is generally viewed positively as it aligns management's interests with shareholder value and incentivizes performance. The low exercise price also suggests a strong potential upside for the executive, which can be a positive signal for future growth.

Positives

• Grant of 250,000 stock options to CEO Michael R. Cavanaugh, aligning management interests with shareholder value.
• Immediate vesting of the options on December 31, 2025, providing immediate equity incentive.
• The exercise price of $0.15 per share is relatively low, offering significant potential upside if the stock price increases.

Future Outlook

This Form 4 filing does not contain forward-looking statements or guidance regarding the company's future performance or strategic direction. It solely reports an insider transaction.

Management Comments

• On December 31, 2025, the Reporting Person was granted options to purchase 250,000 shares of common stock at an exercise price of $0.15. This option vested immediately.

Industry Context

The grant of stock options to a CEO is a common practice in publicly traded companies across various industries, serving as a key component of executive compensation to incentivize long-term performance and align management interests with shareholder value. This specific grant to RANGE IMPACT's CEO reflects a standard approach to executive equity compensation.

Comparison to Industry Standards

• The grant of stock options to a CEO is a standard practice in executive compensation packages across most industries, including technology and growth-oriented sectors.
• Immediate vesting, while less common than phased vesting, can be used to provide strong, immediate incentives or as part of a specific retention strategy.
• The exercise price of $0.15, if significantly below the current market price, represents a substantial potential gain for the executive, which is typical for incentive-based options.

Corporate Governance

Related Party Transactions

• This filing reports an equity compensation grant to an executive officer and director, which is an insider transaction.

Stakeholder Impact

• Shareholders: Potential positive impact due to increased alignment of CEO's interests with long-term shareholder value.
• Employees: May signal confidence in the company's future, potentially boosting morale.
• Management: Direct benefit through equity compensation and incentive to drive stock price appreciation.

Next Steps

• The reporting person may choose to exercise these options at any time between the vesting date (December 31, 2025) and the expiration date (December 31, 2035).

Key Dates

Keywords

RANGE IMPACT, RNGE, Stock Options, Insider Transaction, CEO Compensation, Equity Grant, Michael R. Cavanaugh, Form 4, Executive Compensation